Abstract
530P Ultra low bevacizumab (BEVULTRA-100) as a novel approach in symptomatic management of high grade glioma: Can minimal dose make a difference?
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have